An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial.
INTRODUCTION: A previous randomised controlled trial has demonstrated that oral plus topical mesalazine enema is more effective than oral mesalazine alone for achieving clinical remission in mild-to-moderately active extensive ulcerative colitis (UC). To evaluate whether this strategy is cost-effec...
Main Authors: | Connolly, M, Nielsen, S, Currie, C, Marteau, P, Probert, C, Travis, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis
by: Paridaens, K, et al.
Published: (2024) -
What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?
by: Travis, S
Published: (2005) -
A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.
by: Lee, F, et al.
Published: (1996) -
Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question.
by: Orchard, T, et al.
Published: (2011) -
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
by: Connolly, M, et al.
Published: (2009)